e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Discussion of vaccines, biomarkers and risk factors analysis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between biomarkers at discharge and risk of readmission after community-acquired pneumonia – a retrospective cohort study
P. Petersen (København, Denmark)
Source:
International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Session:
Discussion of vaccines, biomarkers and risk factors analysis
Session type:
Poster Discussion
Number:
4519
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Petersen (København, Denmark). Association between biomarkers at discharge and risk of readmission after community-acquired pneumonia – a retrospective cohort study. 4519
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study
Source: Eur Respir J 2006; 28: Suppl. 50, 351s
Year: 2006
The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020
Year: 2020
The glycemic gap and 90-day mortality in community-acquired pneumonia- A prospective cohort study
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
The effects of antibiotic therapy at the pre-hospital stage on the in-hospital mortality in adults with community-acquired pneumonia in Russia: observational study results.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
New evidence of risk factors for community-acquired pneumonia: a population-based study
Source: Eur Respir J 2008; 31: 1274-1284
Year: 2008
Psychosocial predictors for rapid hospital readmission in COPD: a prospective study
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010
Clinical stability predictors and length of stay in adults with community-acquired pneumonia. Prospective cohort
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016
Etiology of community-acquired pneumonia requiring hospitalization in Chile: a prospective study
Source: Eur Respir J 2005; 26: Suppl. 49, 255s
Year: 2005
Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
Risk factors and implications for readmission of patients following hospitalization for community-acquired pneumonia in South Korea
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Clinical examination and all-cause mortality in non-mild COPD population – prospective study
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept